FocusCancer Immunotherapy

Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer

See allHide authors and affiliations

Sci. Signal.  17 Jan 2017:
Vol. 10, Issue 462, eaal2328
DOI: 10.1126/scisignal.aal2328

Log in to view full text


Navigate This Article